Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

A recent study has uncovered an unexpected connection between our diets and the progression of lung cancer, specifically a ...

The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to ...

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

Dr. Chao H. Huang explains his skepticism regarding a recent study that linked chronic pain to significantly higher lung ...

This week, archaeologists identified depictions of the Milky Way galaxy in ancient Egyptian imagery. A mathematician found a ...